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Identifying a nuclear passport
for HIV
Identification of a protein that pulls HIV into the nucleus explains a key
step in HIV infection.
LORENA ZULIANI-ALVAREZ AND GREG J TOWERS
C
ells have many ways to fight pathogens,
but they still manage to evade our
defenses. HIV, for example, is able to
enter a cell, cross the cytoplasm, and then pass
through the nuclear pore complex to reach the
cell nucleus. The DNA within the virus is sur-
rounded by a capsid that protects against
defense mechanisms of the host, such as nucleic
acid sensors and nucleases (Yan et al., 2010;
Jacques et al., 2016; Francis and Melikyan,
2018; Burdick et al., 2017; Rasaiyaah et al.,
2013).
Previously, it was thought that the capsid can-
not enter the nucleus, but demonstration that
the capsid depends on a nuclear protein called
CPSF6 suggested that it might (Price et al.,
2014; Lee et al., 2010). Now, in eLife, Hans-
Georg Kra€usslich and colleagues – including
David Alejandro Bejarano and Ke Peng as joint
first authors – report new insights into the role
of CPSF6 and the entry of the capsid into the
nucleus (Bejarano et al., 2019). The researchers
– who are based at the University of Heidelberg
and the Chinese Academy of Sciences – tagged
HIV molecules with fluorescent markers and
observed how HIV infected macrophages. The
capsids and CPSF6 proteins were labeled with
antibodies.
Bejarano et al. found that, contrary to previ-
ous assumptions, CPSF6 is essential for HIV
to travel through the nuclear pore into the
nucleus of macrophages. They also found that
CPSF6 associated with capsids inside the
nucleus, suggesting that intact capsids may cross
the nuclear pore. When CPSF6 was depleted, or
could no longer bind to the capsid, the virus
accumulated outside the nucleus. This indicates
a key role for CPSF6 in viral nuclear entry. How-
ever, similar to previous experiments, removing
CPSF6 only modestly reduced the infection lev-
els in macrophages because the capsids used
the remaining low CPSF6 levels.
It is known that the capsid also binds a
nuclear pore protein called Nup153 (Price et al.,
2014). Bejarano et al. suggest that the capsid
first interacts with Nup153 inside the
nuclear pore complex; Nup153 is then displaced
by nuclear CPSF6, which helps to pull the capsid
inside the nucleus (Figure 1). They also propose
an intriguing model to explain how the viral
DNA could integrate into host DNA in the
absence of CPSF6. In line with the hypotheses
proposed in other studies (Achuthan et al.,
2018; Schaller et al., 2011; Sowd et al., 2016),
Bejarano et al. suggest that, in the absence of
CPSF6, the capsid pokes through the nuclear
pore complex enough for the integration of
DNA to take place at the periphery of the
nucleus.
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Two key questions remain. First, why is
CPSF6 required for replication in macrophages
but not in cell lines? One reason for this might
be that, in the absence of binding to a cofactor
such as CPSF6, HIV-1 triggers the production of
interferon in macrophages (Rasaiyaah et al.,
2013). We can think of this in terms of cell lines
’licensing’ otherwise ’illegal’ behaviors by
viruses. For example, capsid uncoating in the
cytoplasm is ’illegal’ in macrophages: that is, it
does not lead to infection. However, such
behaviour is licensed in cell lines and results in
infection. This might be because, in macro-
phages, interferon suppresses mutant HIV-1
infection and uncoated cytosolic capsids are
degraded. In cell lines, on the other hand,
these ’illegal’ viral behaviours are allowed and
the virus can replicate.
Second, what is the role of CPSF6 in T cells
(the immune cells that are the main target of
HIV)? Given their small size and minimal cyto-
plasm, T cells are less suitable for microscopy,
although nuclear transport can be studied in
them (Achuthan et al., 2018). A better under-
standing of how HIV replicates in T cells, and
where capsid uncoating occurs, may reveal fun-
damental differences in infection mechanisms
between T cells and macrophages. In turn, this
may help us understand the relative importance
of HIV replication in macrophages and T cells in
vivo.
This elegant study is a real technical tour de
force, which has overcome significant experi-
mental challenges to answer key questions in
the field. As the techniques used by Bejarano
et al. become widely adopted, we look forward
to rapid advances in our understanding of the
basic biology of HIV that may ultimately lead to
more effective ways to treat, and eventually
cure, HIV and AIDS.
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Figure 1. Schematic of HIV entering the nucleus. The genetic material of HIV is surrounded by a capsid (grey
honeycomb structure). Previously, it was thought that the virus sheds this capsid before it enters the nucleus.
Bejarano et al. now show that, in macrophages, the virus retains its capsid while entering the nucleus, through the
nuclear pore complex (NPC; turquoise), Two proteins, CPSF6 (blue circle), and Nup153 (lilac oval) control this
process. First, Nup153 binds to the capsid as it associates with the pore complex. CPSF6 then binds to the same
region of the capsid, displacing the Nup153, and helping the capsid enter the nucleus. Finally, the capsid
‘uncoats’ and the viral DNA integrates into the host DNA with the help of an enzyme called integrase (green oval)
and a protein called LEDGF (purple oval).
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